Bristol-Myers Squibb
BMY
BMY
1,409 hedge funds and large institutions have $75.1B invested in Bristol-Myers Squibb in 2014 Q4 according to their latest regulatory filings, with 172 funds opening new positions, 437 increasing their positions, 572 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,409
Holders Change
+108
Holders Change %
+8.3%
% of All Funds
37.6%
Holding in Top 10
62
Holding in Top 10 Change
+19
Holding in Top 10 Change %
+44.19%
% of All Funds
1.65%
New
172
Increased
437
Reduced
572
Closed
52
Calls
$663M
Puts
$1.07B
Net Calls
-$404M
Net Calls Change
-$469M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$446M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$349M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$299M |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$209M |
| 5 |
O
OppenheimerFunds
New York
|
+$202M |
Top Sellers
| 1 |
IC
Institutional Capital
Chicago,
Illinois
|
-$262M |
| 2 |
JPMorgan Chase & Co
New York
|
-$218M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$188M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$166M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$162M |